Results from TRIUMPH [EUROPE], a Real-World Observational Study on the 3-Month Effectiveness of Galcanezumab Versus Traditional Oral Migraine Preventive Medications.

Emgality (galcanezumab-gnlm) - Eli Lilly, Daiichi Sankyo

http://www.ncbi.nlm.nih.gov/pubmed/42047714

Cristina Tassorelli; Diego Novick; Georgia Martimianaki; Maurice Vincent; Patricia Pozo Rosich; Rebecca L Robinson; Saygin Gonderten

Apr 29, 2026